Clinical Trials Browser

Breast Neoplasms × atezolizumab × 30 days × Clear all

NCT03424005 2026-03-16

Morpheus-panBC

Phase 1/2 Recruiting

Breast Neoplasms

NCT04873362 2026-03-04

Astefania

Phase 3 Active not recruiting

Breast Neoplasms